CLINICAL CORE - CORE B: ABSTRACT The Clinical Core (Core B) plays a pivotal role in the BIOCARD Study. The Clinical Core is responsible for: (1) the re-enrollment of BIOCARD subjects, (2) scheduling subjects for all visits and all study procedures (including clinical/cognitive assessments, lumbar punctures for collection of cerebrospinal fluid, magnetic resonance imaging (MRI) scans, and positron emission tomography scans using Pittsburgh compound B (PiB/PET scans), (3) completion of annual clinical and cognitive assessments, (4) acquisition of ante-mortem autopsy approval, (5) implementation of subject retention activities, (6) analyses of clinical and cognitive data concerning the study participants, (7) working collaboratively with the other Cores to examine combinations of biomarkers that are predictive of progression and to examine the order and pattern of biomarker change during preclinical AD, and (8) sharing of clinical and cognitive data with investigators in the field via the BIOCARD website, using the approved BIOCARD Study data sharing procedures.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Research Program--Cooperative Agreements (U19)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1-ZIJ-5 (M3))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Johns Hopkins University
United States
Zip Code
Sacktor, Ned; Soldan, Anja; Grega, Maura et al. (2017) The BIOCARD Index: A Summary Measure to Predict Onset of Mild Cognitive Impairment. Alzheimer Dis Assoc Disord 31:114-119
Pettigrew, Corinne; Soldan, Anja; Sloane, Kelly et al. (2017) Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease. Neuroimage Clin 16:439-446
Tward, Daniel; Miller, Michael; Trouve, Alain et al. (2017) Parametric Surface Diffeomorphometry for Low Dimensional Embeddings of Dense Segmentations and Imagery. IEEE Trans Pattern Anal Mach Intell 39:1195-1208
Gross, Alden L; Hassenstab, Jason J; Johnson, Sterling C et al. (2017) A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortium. Alzheimers Dement (Amst) 8:147-155
Cai, Qing; Wang, Mei-Cheng; Chan, Kwun Chuen Gary (2017) Joint modeling of longitudinal, recurrent events and failure time data for survivor's population. Biometrics 73:1150-1160
Varma, V R; Varma, S; An, Y et al. (2017) Alpha-2 macroglobulin in Alzheimer's disease: a marker of neuronal injury through the RCAN1 pathway. Mol Psychiatry 22:13-23
Pettigrew, Corinne; Soldan, Anja; Zhu, Yuxin et al. (2017) Cognitive reserve and cortical thickness in preclinical Alzheimer's disease. Brain Imaging Behav 11:357-367
Mori, Susumu; Kageyama, Yusuke; Hou, Zhipeng et al. (2017) Elucidation of White Matter Tracts of the Human Amygdala by Detailed Comparison between High-Resolution Postmortem Magnetic Resonance Imaging and Histology. Front Neuroanat 11:16
Soldan, Anja; Pettigrew, Corinne; Cai, Qing et al. (2017) Cognitive reserve and long-term change in cognition in aging and preclinical Alzheimer's disease. Neurobiol Aging 60:164-172
Leoutsakos, J-M; Gross, A L; Jones, R N et al. (2016) 'Alzheimer's Progression Score': Development of a Biomarker Summary Outcome for AD Prevention Trials. J Prev Alzheimers Dis 3:229-235

Showing the most recent 10 out of 42 publications